PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease ReportsCampylobacter infections
MeSH D002169 - campylobacter infections
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D016905:Gram-negative bacterial infections
29 Companies
16 Drugs
$
Success rate
D002169: 
Campylobacter infections
121 Companies
18 Drugs
$
Success rate
Events Timeline
Loading
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
0%
0/1
Phase 2
100%
2/2
Phase 3
80%
8/10
Approved: 8Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
Doxycycline hyclate,
Erythromycin,
Erythromycin estolate,
Erythromycin gluceptate,
Erythromycin lactobionate,
Erythromycin stearate,
Tetracycline
Mylan
Doxycycline hyclate,
Erythromycin,
Erythromycin estolate,
Erythromycin gluceptate,
Erythromycin lactobionate,
Erythromycin stearate
Mayne Group
Doxycycline hyclate
Johnson & Johnson
Erythromycin,
Erythromycin estolate,
Erythromycin gluceptate,
Erythromycin lactobionate,
Erythromycin stearate
Bausch Health Companies
Benzoyl peroxide,
Erythromycin,
Erythromycin estolate,
Erythromycin gluceptate,
Erythromycin lactobionate,
Erythromycin stearate,
Tetracycline
Bayer
Ciprofloxacin
Pfizer
Doxycycline,
Doxycycline hyclate,
Erythromycin,
Erythromycin estolate,
Erythromycin gluceptate,
Erythromycin lactobionate,
Erythromycin stearate,
Tetracycline
1
2
3
4
5
6
...
9
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use